Skip to main content
Figure 5 | Molecular Cancer

Figure 5

From: Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations

Figure 5

(A) Kaplan Meier survival analysis in CRC patients with over expression of Trail R1 had a better overall survival of 68.1% at 5 years as compared to 53.9% with reduced TRAIL-R1 expression (p = 0.0124). (B) CRC patients Trail R2 also showed a better overall survival as of 67.3% compared to 57.6% with reduced TRAIL-R2 expression ( p = 0.0211).

Back to article page

Molecular Cancer

ISSN: 1476-4598